Feasibility of surveillance resistance to antituberculosis drugs :Europe, 1997

V Schwoebel; D Antoine; J Veen; The national coordinators for tuberculosis surveillance

doi:10.2807/esm.05.04.00036-en

Research Articles Open Access

Like 0

This item has no PDF Download

Feasibility of surveillance resistance to antituberculosis drugs :Europe, 1997
V Schwoebel¹ , D Antoine¹ , J Veen² , The national coordinators for tuberculosis surveillance³
View Affiliations Hide Affiliations

Affiliations: ¹ Institut de Veille Sanitaire, Saint-Maurice, France ² Royal Netherlands Tuberculosis Association, The Hague, The Netherlands ³ The national coordinators for tuberculosis surveillance are listed at the beginning of the article

Correspondence:
View Citation Hide Citation

Citation style for this article: Schwoebel V, Antoine D, Veen J, The national coordinators for tuberculosis surveillance. Feasibility of surveillance resistance to antituberculosis drugs :Europe, 1997. Euro Surveill. 2000;5(4):pii=36. https://doi.org/10.2807/esm.05.04.00036-en

Abstract

Between 28% and 100% of isolates from ten countries from the EuroTB network in 1997 were reported with data on antituberculosis drug susceptibility. Drug resistance was commoner among foreign-born patients and in general among patients who had been treate